Blast traumatic brain injury–induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon‐like peptide‐1 receptor agonist, exendin‐4
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Introduction: Blast traumatic brain injury (B‐TBI) affects military and civilian personnel. Presently, there are no approved drugs for blast brain injury. Methods: Exendin‐4 (Ex‐4), administered subcutaneously, was evaluated as a pretreatment (48 hours) and postinjury treatment (2 hours) on neurodegeneration, behaviors, and gene expressions in a murine open field model of blast injury. Results: B‐TBI induced neurodegeneration, changes in cognition, and genes expressions linked to dementia disorders. Ex‐4, administered preinjury or postinjury, ameliorated B‐TBI–induced neurodegeneration at 72 hours, memory deficits from days 7–14, and attenuated genes regulated by blast at day 14 postinjury. Discussion: The present data suggest shared pathologic processes between concussive and B‐TBI, with end points amenable to beneficial therapeutic manipulation by Ex‐4. B‐TBI–induced dementia‐related gene pathways and cognitive deficits in mice somewhat parallel epidemiologic studies of Barnes et al. who identified a greater risk in US military veterans who experienced diverse TBIs, for dementia in later life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderate and severe traumatic brain injury in adults
Maas, A. I., Stocchetti, N., & Bullock, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70164-9 · Cited by 2,123
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“The probed sections were mounted onto 2% gelatin-coated slides and stained with FJB (Millipore; AG310) as described by Schmued and Hopkins [40].”
MethodGoldstein, L. E., Fisher, A. M., Tagge, C. A., Zhang, X.-L., Velisek, L., Sullivan, J. A., Upreti, C., Kracht, J. M., Ericsson, M., Wojnarowicz, M. W., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003716 · Cited by 958
Exenatide and the treatment of patients with Parkinson's disease
Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., Djamshidian, A., Ell, P., Soderlund, T., Whitton, P., Wyse, R., Isaacs, T., Lees, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68295 · Cited by 529 · cited 2×
“Based on this preclinical data, and clinical trials of Ex-4 ongoing in both Parkinson’s disease and Alzheimer’s disease [23,72,73], further explorations of such agents in diverse animal models of B-TBI may help to define possible treatment options for clinical TBI–induced neurodegenerative dementia.”
BackgroundMethodThe molecular pathophysiology of concussive brain injury
Barkhoudarian, G., Hovda, D. A., & Giza, C. C. (2011) · Clinics in Sports Medicine · doi:10.1016/j.csm.2010.09.001 · Cited by 492 · cited 2×
“In recent years, advances in our knowledge of the molecular mechanisms that regulate the health and survival of neurons, together with an understanding of key pathways induced by TBI that lead to neuronal dysfunction and death [6–8], are being applied to the development of experimental drugs with properties potentiall…”
BackgroundPathophysiology of traumatic brain injury
Greve, M. W., & Zink, B. J. (2009) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20104 · Cited by 477 · cited 2×
“A cascade of pathologic events may then follow that leads to further secondary brain injury that takes place from minutes to days after the trauma [9].”
BackgroundTraumatic brain injury and young onset dementia: a nationwide cohort study
Nordström, P., Michaëlsson, K., Gustafson, Y., & Nordström, A. (2014) · Annals of Neurology · doi:10.1002/ana.24101 · Cited by 208 · cited 1×
“Although the proposed link between TBI and the subsequent development of dementia is still controversial, an ever expanding number of epidemiologic studies point toward a strong association between TBI, primarily concussive TBI but not blast TBI, and the development of dementia syndromes in later life [57–65].”
BackgroundHoffer, M. E., Balaban, C., Slade, M. D., Tsao, J. W., & Hoffer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054163 · Cited by 207
Self-citation
Cited by
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123
“GLP-1R agonists are protective in models of stroke, traumatic brain injury (TBI), AD, and the MPTP intoxication model of PD 4,5,8,12,13 .”
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Self-citationProtective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108
Blast Exposure Leads to Accelerated Cellular Senescence in the Rat Brain
Arun, P., Rossetti, F., Wilder, D. M., Sajja, S., Van Albert, S. A., Wang, Y., Gist, I. D., & Long, J. B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00438 · Cited by 30
Noguchi, T., Katoh, H., Nomura, S., Okada, K., & Watanabe, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1342944 · Cited by 20
Metadata
- Authors
- Tweedie, D., Rachmany, L., Rubovitch, V., Li, Y., Holloway, H. W., Lehrmann, E., Zhang, Y., Becker, K. G., Perez, E., Hoffer, B. J., Pick, C. G., & Greig, N. H.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2015-08-29
- Volume
- 12
- Issue
- 1
- Pages
- 34-48
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1155323411
- Cited by
- 58
- References
- 16
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blast traumatic brain injury–induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon‐like peptide‐1 receptor agonist, exendin‐4. https://app.cochat.ai/papers/10.1016/j.jalz.2015.07.489
- The paper
- Tweedie, D., Rachmany, L., Rubovitch, V., Li, Y., Holloway, H. W., Lehrmann, E., Zhang, Y., Becker, K. G., Perez, E., Hoffer, B. J., Pick, C. G., & Greig, N. H. (2016). Blast traumatic brain injury–induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon‐like peptide‐1 receptor agonist, exendin‐4. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.07.489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.